Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis

We present a case report of a patient with cryoglobulin-vasculitis caused by multiple myeloma in Durie/Salmon stage I refractory to conventional therapy modalities treated with high-dose chemotherapy followed by autologous blood stem cell transplantation. While clinical symptoms of vasculitis disapp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hillengaß, Jens (VerfasserIn) , Ho, Anthony Dick (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Waldherr, Rüdiger (VerfasserIn) , Möhler, Thomas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 11 October 2008
In: International journal of hematology
Year: 2008, Jahrgang: 88, Heft: 4, Pages: 454-456
ISSN:1865-3774
DOI:10.1007/s12185-008-0177-1
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s12185-008-0177-1
Volltext
Verfasserangaben:J. Hillengass, A. D. Ho, H. Goldschmidt, R. Waldherr, T. M. Moehler
Beschreibung
Zusammenfassung:We present a case report of a patient with cryoglobulin-vasculitis caused by multiple myeloma in Durie/Salmon stage I refractory to conventional therapy modalities treated with high-dose chemotherapy followed by autologous blood stem cell transplantation. While clinical symptoms of vasculitis disappeared, elevated cryoglobulin levels persisted. Therefore we conclude that the relief of symptoms was caused by an immunomodulation induced by the autologous stem cell transplantation.
Beschreibung:Gesehen am 14.01.2022
Beschreibung:Online Resource
ISSN:1865-3774
DOI:10.1007/s12185-008-0177-1